OSI Systems [OSIS] on Thursday said it has agreed to acquire an explosive trace detection (ETD) business from Britain’s Smiths Group for $75.5 million in cash, a deal that many industry observers believed likely and which fills a gap in the company’s portfolio with a mature technology that is widely deployed.

The ETD business that OSI Systems is buying previously was part of the Morpho Detection business acquired Smiths in April from France’s Safran Group. Smiths Group’s Smiths Detection division already had its own mature trace business and regulators in the U.S. and Europe stipulated that Smiths must divest the Morpho ETD unit as a condition for approving the acquisition of Morpho Detection.

Smiths Group will retain its legacy ETD products following the sale of the trace business it recently acquired from Safran Group. Shown here is Smiths' Ionscan 600 portable narcotics and explosive trace detector. Photo: Smiths Group
Smiths Group will retain its legacy ETD products following the sale of the trace business it recently acquired from Safran Group. Shown here is Smiths’ Ionscan 600 portable narcotics and explosive trace detector. Photo: Smiths Group

OSI’s acquisition of the Massachusetts-based ETD business is expected to close in mid-2017 subject to regulatory approvals in the U.S., the European Commission and Portugal, Smiths said.

The ETD business that OSI’s Rapiscan Systems division is acquiring from Smiths has a worldwide installed base of more than 11,000 units, and competes globally with Smiths’ legacy ETD products and L3 Technologies [LLL], which in January year acquired the trace detection assets of the former Implant Sciences Corp.

“The acquisition of this ETD business is highly complementary to our current operations and this natural fit will enable us to better serve the unique needs of our customers seeking to secure airports, borders, public venues, and critical infrastructure,” Deepak Chopra, OSI’s chairman and CEO, said in a statement. “This acquisition fills a gap in our aviation checkpoint offering that currently includes passenger screening, carry-on baggage inspection, and automated tray return solutions.”

OSI’s Rapiscan division currently sells Advanced Technology X-Rays systems, explosives detection systems (EDS) for scanning checked bags, walk-through metal detectors, body imagers, radiation detection equipment, cargo and vehicle inspection systems, and automated tray return equipment to customers worldwide. The company has an ETD product but it isn’t widely sold or deployed.

OSI said it will fund the acquisition from its existing $525 million credit facility. The company expects the transaction to be accretive to its earnings in its fiscal year 2018, which begins on July 1.

Jefferies aerospace and defense analyst Sheila Kahyaoglu said in a note to clients on Thursday that OSI is acquiring the ETD business at a low price. She estimates that the trace business has about $65 million in annual sales and could add between 15 and 20 cents to per share earnings in FY ’18.

Smiths’ financial advisor on the deal is Gleacher Shacklock.

In addition to the ETD products it acquired as part of the deal for Morpho Detection, that acquisition also gave it a strong position in the global market for EDS systems.